SEC Form 4 · accession 0001437749-17-019680
Perspective Therapeutics, Inc. · CATX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas C Lavoy
Officer — CEO and Chairman of the Board · Director
Period of report
Nov 20, 2017
Accepted (ET)
Nov 21, 2017 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000728387
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 20, 2017 | M | 82,810 | $0.605 | A | 266,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.605 | Nov 20, 2017 | M | 82,810 | D | — | Jun 27, 2027 | Common Stock | 82,810 | 632,190 | D |
Explanation of responses
- F1715,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested. The shares exercised on 11/20/2017 represent a portion of the shares that vested on 6/27/2017.